Advertisement
Canada markets open in 4 hours 13 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7312
    +0.0014 (+0.20%)
     

  • CRUDE OIL

    82.85
    +0.04 (+0.05%)
     

  • Bitcoin CAD

    87,688.03
    -3,185.09 (-3.50%)
     

  • CMC Crypto 200

    1,361.17
    -21.40 (-1.55%)
     

  • GOLD FUTURES

    2,339.40
    +1.00 (+0.04%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,501.50
    -163.00 (-0.92%)
     

  • VOLATILITY

    16.20
    +0.23 (+1.44%)
     

  • FTSE

    8,093.43
    +53.05 (+0.66%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

NNOX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 6, 2021 in the Class Action Filed on Behalf of Nano-X Imaging Ltd. Limited Shareholders

Newsfile Corp.
·2 min read

New York, New York--(Newsfile Corp. - November 28, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Nano-X Imaging Ltd. (NASDAQ: NNOX) alleging that the Company violated federal securities laws.

Class Period: June 17, 2021 to August 18, 2021
Lead Plaintiff Deadline: December 6, 2021
No obligation or cost to you.

Learn more about your recoverable losses in NNOX:
https://www.kleinstocklaw.com/pslra-1/nano-x-imaging-ltd-loss-submission-form-2?id=21602&from=5

Nano-X Imaging Ltd. NEWS - NNOX NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Nano-X Imaging Ltd. made materially false and/or misleading statements and/or failed to disclose that: (i) Nano-X's 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC's regulatory and commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

ADVERTISEMENT

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Nano-X you have until December 6, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Nano-X securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the NNOX lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link.

ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105416